Metabotropic glutamate receptor 5 NAMs remain a promising disease modifying treatment in HD since they are capable of reversing disease pathology in both sexes, but it is possible that extended treatment in females is required to accomplish a significant recovery in motor and cognitive symptoms. Here, GRM5 is linked to Huntington disease.